Product mentioned on podcasts
abelacimab
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links. As an Amazon Associate, SignalCast earns from qualifying purchases.
Who mentioned it
“carving abelacimab from Novartis in 2019, running phase two trials showing 62–89% bleeding reduction versus Xarelto”
Mentioned on: Pathfinders in Biopharma